HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Draft genome sequence data of Erysipelothrix rhusiopathiae vaccine strain VR-2.

Abstract
Data on the draft genome sequence of Erysipelothrix rhusiopathiae strain VR-2 is presented in this report. E. rhusiopathiae strain VR-2 is a commercial attenuated vaccine widely used in Russia and a number European countries for immunization of pigs against swine erysipelas. The draft genome sequence of 1,704,727 bp in length included 1415 protein sequences, 50 tRNA genes and 3 rRNA genes according NCBI Prokaryotic Genomes Automatic Annotation Pipeline results. The draft genome sequence data of E. rhusiopathiae strain VR-2 is available in GenBank under the accession nos. RJTK00000000.1, PRJNA504614 and SAMN10395786 for Genome, Bioproject and Biosample, respectively. The obtained sequence data may be helpful for searching genetic markers of VR-2, aimed to develop assays to discriminate between field isolates and this vaccine strain of E. rhusiopathiae.
AuthorsSvetlana Kovalchuk, Anna Babii
JournalData in brief (Data Brief) Vol. 33 Pg. 106352 (Dec 2020) ISSN: 2352-3409 [Electronic] Netherlands
PMID33083506 (Publication Type: Journal Article)
Copyright© 2020 The Authors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: